A novel microglia-targeting strategy based on nanoparticle-mediated delivery of miR-26a-5p for long-lasting analgesia in chronic pain
Journal of Nanobiotechnology · 2024
DOI: 10.1186/s12951-024-02420-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nanobiotechnology, 2024. Verfasst von Yitian Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China. Hauptthemen laut MEDLINE: Chronic Pain, MicroRNAs, Neuralgia, Analgesia. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Yiyang Healthcare Charity Foundation, Discipline Construction Fund of Central People's Hospital of Zhanjiang.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Accumulating evidence supports the notion that microglia play versatile roles in different chronic pain conditions. However, therapeutic strategies of chronic pain by targeting microglia remain largely overlooked. This study seeks to develop a miRNA-loaded nano-delivery system by targeting microglia, which could provide a decent and long-lasting analgesia for chronic pain. Surface aminated mesoporous silica nanoparticles were adopted to load miR-26a-5p, a potent analgesic miRNA, by electrostatic adsorption, which can avoid miR-26a-5p is rapidly released and degraded. Then, targeting peptide MG1 was modified on the surface of aminated mesoporous silica particles for microglia targeting. In peripheral nerve injury induced neuropathic pain model, a satisfactory anti-allodynia effect with about 6 weeks pain-relief duration were achieved through targeting microglia strategy, which decreased microglia activation and inflammation by Wnt5a, a non-canonical Wnt pathway. In inflammatory pain and chemotherapy induced peripheral neuropathic pain, microglia targeting strategy also exhibited more efficient analgesia and longer pain-relief duration than others. Overall, we developed a microglia-targeting nano-delivery system, which facilitates precisely miR-26a-5p delivery to enhance analgesic effect and duration for several chronic pain conditions. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
- Department of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
- Neuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Key Laboratory for Neuroscience, Ministry of Education/National Health Commission, National Health Commission and State K…
- Guangdong Provincial Key Laboratory of Construction and Detection in Tissue Engineering, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
- Guangdong Provincial Key Laboratory of Construction and Detection in Tissue Engineering, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, People's Republic of China. ss.hhh89@hotmail.…
- Department of Anesthesiology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China. taotaomzk@smu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Guangdong Yiyang Healthcare Charity Foundation
- Discipline Construction Fund of Central People's Hospital of Zhanjiang
- Science and Technology Planning Project of Guangzhou, China
- Natural Science Foundation of Guangdong Province, China
- National Key R&D Program of China
- Discipline Construction Fund of Central People’s Hospital of Zhanjiang
Zitieren
APA
Lu, Y., Liu, S., Wang, P., Guo, X., Qin, Z., Hou, H., & Tao, T. (2024). A novel microglia-targeting strategy based on nanoparticle-mediated delivery of miR-26a-5p for long-lasting analgesia in chronic pain. Journal of Nanobiotechnology. https://doi.org/10.1186/s12951-024-02420-9
Vancouver
Lu Y, Liu S, Wang P, Guo X, Qin Z, Hou H, et al. A novel microglia-targeting strategy based on nanoparticle-mediated delivery of miR-26a-5p for long-lasting analgesia in chronic pain. Journal of Nanobiotechnology. 2024. doi:10.1186/s12951-024-02420-9
BibTeX
@article{Lu2024,
author = {Lu, Yitian and Liu, Shuai and Wang, Peng and Guo, Xiangna and Qin, Zaisheng and Hou, Honghao and Tao, Tao},
title = {A novel microglia-targeting strategy based on nanoparticle-mediated delivery of miR-26a-5p for long-lasting analgesia in chronic pain},
journal = {Journal of Nanobiotechnology},
year = {2024},
doi = {10.1186/s12951-024-02420-9}
}
EUVIMED